U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. PEDIARIX
  1. Vaccines

PEDIARIX

STN: BL 103907
Proper Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine
Tradename: PEDIARIX
Manufacturer: GlaxoSmithKline
Indications:

  • PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis.
  • PEDIARIX is approved for use as a 3-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers.
  • PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the seventh birthday).

Product Information

Supporting Information

Back to Top